Braidwell LP Portfolio Holdings

Braidwell LP

  • $3.19 Trillion
  • Q2 2024

Braidwell LP has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $3.19 Trillion distributed in 75 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Guardant Health Inc with a value of $208B, Bridgebio Pharma Inc with a value of $143B, Novocure LTD with a value of $130B, Nuvasive Inc with a value of $110B, and Neurocrine Biosciences Inc with a value of $104B.

Examining the 13F form we can see an increase of $85B in the current position value, from $3.1T to 3.19T.

Braidwell LP is based out at Stamford, CT

Below you can find more details about Braidwell LP portfolio as well as his latest detailed transactions.

Portfolio value $3.19 Trillion
Healthcare: $1.57 Trillion
Consumer Defensive: $9.83 Billion

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$13.5M
$6.69 Billion 0.21% of portfolio
2,477,614
Q2 2024 Added 4.2%
$32.6M
$2.67 Billion 0.08% of portfolio
694,525
Q2 2024 Reduced 71.07%

Summary

  • Portfolio
  • No. of Stocks 75
  • Current Value $3.19 Trillion
  • Prior Value $3.1 Trillion
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 22 stocks
  • Additional Purchases 31 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 13 stocks
Track This Portfolio

Track Braidwell LP Portfolio

Follow Braidwell LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

News

Stay updated on Braidwell LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email